Announcements
Sidley Advises PhaseV in Its US$50 Million Series A Financing
May 14, 2025
Sidley advised PhaseV Trials Inc., a leader in AI/ML-driven clinical development, in its US$50 million Series A financing round. The round was co-led by Accel and Insight Partners, with participation from Viola Ventures, Exor Ventures, and LionBird.
For additional information, please refer to the press release.
The Sidley team was led by Dr. Idan Netser and Jake Funk (Emerging Companies and Venture Capital).
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Werewolf Therapeutics in Merger with Ambros Therapeutics and Concurrent US$150 Million Private PlacementAugust 21, 2026The Wait is Over: SEC Proposes “Regulation Crypto Assets,” A Bespoke Offering Regime for Crypto Investment ContractsAugust 20, 2026Sidley Represents Clearlake Capital Group in Its Investment in Databricks’ US$5 Billion Funding RoundAugust 19, 2026Sidley Represents FormX in Its US$12.5 Million Series Seed FinancingAugust 11, 2026Sidley Represents Sapiom in US$35 Million Series A FinancingAugust 5, 2026Sidley Represents CAIS in Its US$170 Million Series D FinancingJuly 29, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory